Dr. Colleen L Jay, United States
Comparable Kidney Transplant Outcomes in Selected Patients with a BMI ≥40: A Personalized Medicine Approach to Recipient Selection

Dr. Ankur Mittal, India
Outcome analysis of patients with genetic mutations of complement regulatory proteins in relation to incidence of post renal transplant thrombotic microangiopathy

Miss Yvonne van der Veen, Netherlands
Inadequate Iodine Intake and Long-Term Outcomes after Kidney Transplantation

Miss Leticia Yukari Okabe, Brazil
Clinical outcomes among patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) submitted to kidney transplant compared with a non-ADPKD paired group: a propensity score matched cohort study.

Dr. Nadzeya Rapetskaya, Belarus
Audit of posttransplant IgA nephropathy treatment strategies: single center study

Dr. Peter E Frasco, United States
Postoperative statin therapy is not associated with reduced incidence of venous thromboembolic events following kidney transplantation

Ana Catalina Alvarez Elias, Mexico
Effect of CYP3A5 genotype-guided versus conventional initial dose of tacrolimus in children with kidney transplants

Ana Catalina Alvarez Elias, Mexico
Influence of tacrolimus CYP3A5 polymorphisms on the dose-level response after pediatric kidney transplantation